ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 611

Autophagy and Unfolded Protein Response: A Fine Balance That Can Influence the Pathogenesis of Ankylosing Spondylitis and Inflammatory Bowel Disease

Nigil Haroon1, Giuliana Guggino2, Zhenbo Zhang1, Kirby Yee3, Hasan Abdullah4, Ricardo Alessandro5, Stefania Raimondo5, Giovanni Triolo5 and Francesco Ciccia2, 1Toronto Western Research Institute, Toronto, ON, Canada, 2Rheumatology Unit, University of Palermo, Palermo, Italy, 3McMaster University, Hamilton, ON, Canada, 4University of Toronto, Toronto, ON, Canada, 5University of Palermo, Palermo, Italy

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Inflammation, inflammatory bowel disease (IBD) and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose

We have shown an increase in the unfolded protein response (UPR) with decreased ERAP1 or ERAP2 function in an in vitrosystem. Similarly UPR has been demonstrated to correlate with onset of disease in the HLA-B27 rat model. UPR has been difficult to demonstrate in the gut of AS patients but autophagy is upregulated.  ERAP2 is associated with both AS and inflammatory bowel disease (IBD). Here we explore the moderating effect of autophagy on UPR.

Methods

Lamina Propria Mononuclear cells (LPMC) were isolated from terminal ileal biopsies of 10 AS patients. Autophagy was suppressed with 2 agents anisomycin and 3-MA. In parallel an in vitro system was established with C1R-B27 cells (B-lymphoblastoid cells with stable HLA-B27 expression) and the presence of autophagy in these cells were established with electron microscopy as well as by transfecting these cells with LC3-RFP followed by confocal microscopy. Autophagy was suppressed in C1R-B27 cells using 3-MA.

In both LPMC and C1R B27 cells, suppression of autophagy was demonstrated by RT-PCR of appropriate markers. Changes in MHC-I free heavy chain (FHC) expression were tested by HC10 staining and flow cytometry. Changes in UPR following inhibition were tested by XBP1 splicing assay and RT-PCR for BiP, CHOP, PERK, GADD34 and PDIA6.

Results

Electron and confocal microscopy demonstrated autophagy in C1R-B27 cells. Autophagy was in a dynamic state in the C1R cells as demonstrated by changes with rapamycin a stimulator of autophagy. Significant suppression of autophagy was noted in both LPMCs and C1R-B27 cells.  Following autophagy suppression there was a significant increase in FHC expression in both C1R cells and LPMCs. In parallel we demonstrated increase in UPR markers in both LPMCs and C1R cells.

Conclusion

The inability to demonstrate UPR in some in vivo studies could be due to compensation by autophagy. Inhibition of autophagy led to significant increase in UPR in both LPMC and C1R cells. Autophagy and UPR regulate each other and perturbations of this fine balance can influence the pathogenesis of AS and IBD.


Disclosure:

N. Haroon,
None;

G. Guggino,
None;

Z. Zhang,
None;

K. Yee,
None;

H. Abdullah,
None;

R. Alessandro,
None;

S. Raimondo,
None;

G. Triolo,
None;

F. Ciccia,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/autophagy-and-unfolded-protein-response-a-fine-balance-that-can-influence-the-pathogenesis-of-ankylosing-spondylitis-and-inflammatory-bowel-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology